- Total revenue of $91.7 million.
- Income from operations of $17.9 million, or operating margin of 19.6 percent.
- Net income available to common stockholders of $11.4 million, or $0.34 per diluted share.
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced its financial results for the second quarter ended June 30, 2012. SECOND QUARTER 2012 HIGHLIGHTS